<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03966001</url>
  </required_header>
  <id_info>
    <org_study_id>UU-SUAM-2019-8/34</org_study_id>
    <nct_id>NCT03966001</nct_id>
  </id_info>
  <brief_title>Cesarean Scar Defect Formation After First Cesarean Section.</brief_title>
  <official_title>Formation of the Cesarean Scar Defect After the First Cesarean. A Prospective Observational Study of Planned Versus Emergency Cesarean Sections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uludag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uludag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective observational study which will monitor how cesarean section in
      the first pregnancy will develop a cesarean scar defect. Patients with planned cesarean
      section in their first pregnancy and those with an emergency cesarean section will be
      monitored for one year.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cesarean scar defects, which may develop after cesarean deliveries, are associated with
      menstrual bleeding problems, infertility, and poor obstetric outcomes. No matter how
      excellent and standard surgical technique is applied, scar defects may develop after cesarean
      section. However, when cesarean operation decision is taken, the existing operational
      conditions can affect the formation of cesarean scar defect in the future. Although the
      surgical technique is the same, a planned cesarean operation and an emergency cesarean
      section may differ for a future cesarean scar defect that may develop in the future.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 25, 2019</start_date>
  <completion_date type="Anticipated">December 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cesarean Scar Defect (Niche)</measure>
    <time_frame>10 minutes</time_frame>
    <description>The presence of a &quot;niche&quot; at the site of cesarean delivery scar diagnosed at the time of transvaginal ultrasonography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postmenstrual spotting</measure>
    <time_frame>7-10 days</time_frame>
    <description>Any vaginal bleeding that occurs after the usual menstrual period.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Cesarean Section Complications</condition>
  <condition>Cesarean Wound Disruption</condition>
  <condition>Cesarean Wound; Dehiscence</condition>
  <arm_group>
    <arm_group_label>Planned Cesarean Group</arm_group_label>
    <description>Pregnant women undergoing a planned cesarean section at 38-42 gestational week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Emergency Cesarean Group</arm_group_label>
    <description>Pregnant women who are planning to give normal birth between 38-42 weeks of gestation but have to been performed an urgent cesarean section due to an emergency such as acute fetal distress, cephalo-pelvic disproportion or another obstetrical condition.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transvaginal sonography at six months after cesarean section</intervention_name>
    <description>In the sixth month after cesarean section, Women in both groups will undergo a detailed pelvic examination and transvaginal ultrasonographic evaluation for the cesarean scar defect.</description>
    <arm_group_label>Emergency Cesarean Group</arm_group_label>
    <arm_group_label>Planned Cesarean Group</arm_group_label>
    <other_name>Transvaginal sonography 6th month after C/S</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transvaginal sonography at twelve months after cesarean section</intervention_name>
    <description>In the twelfth month after cesarean section, Women in both groups will undergo a detailed pelvic examination and transvaginal ultrasonographic evaluation for the cesarean scar defect.</description>
    <arm_group_label>Emergency Cesarean Group</arm_group_label>
    <arm_group_label>Planned Cesarean Group</arm_group_label>
    <other_name>Transvaginal sonography 12th month after C/S</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of pregnant patients who are in their 38-42th gestational
        weeks and who undergo planned or emergency cesarean section.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-45-year-old patients

          -  Patients who have undergone a planned or emergency cesarean section within the 38-42th
             gestational week.

        Exclusion Criteria:

          -  Spontaneous vaginal birth

          -  Preterm birth

          -  Pregnant women with an obstetrical or gynecological complication.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women at 38-42th gestational weeks.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gurkan Uncu, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Uludag University Hospital, 16059, Bursa, Turkey</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bilge Cetinkaya Demır, Assoc.Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uludag University Hospital, 16059, Bursa, Turkey</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adnan Orhan, M.D.</last_name>
    <phone>+905056337102</phone>
    <email>dr.adnan.orhan@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isil Kasapoglu, M.D</last_name>
    <phone>+905305455848</phone>
    <email>kasapogluisil@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uludag University Hospital, Department of Obstetrics and Gynecology</name>
      <address>
        <city>Bursa</city>
        <state>Ozluce</state>
        <zip>16059</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adnan Orhan, M.D.</last_name>
      <phone>+90 505 6337102</phone>
      <email>dr.adnan.orhan@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ebru Sakar, M.D</last_name>
      <phone>+90 507 8517109</phone>
      <email>ebru_sakar@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Antila-Långsjö R, Mäenpää JU, Huhtala H, Tomás E, Staff S. Comparison of transvaginal ultrasound and saline contrast sonohysterography in evaluation of cesarean scar defect: a prospective cohort study. Acta Obstet Gynecol Scand. 2018 Sep;97(9):1130-1136. doi: 10.1111/aogs.13367. Epub 2018 May 29.</citation>
    <PMID>29754409</PMID>
  </reference>
  <reference>
    <citation>Setubal A, Alves J, Osório F, Guerra A, Fernandes R, Albornoz J, Sidiroupoulou Z. Treatment for Uterine Isthmocele, A Pouchlike Defect at the Site of a Cesarean Section Scar. J Minim Invasive Gynecol. 2018 Jan;25(1):38-46. doi: 10.1016/j.jmig.2017.09.022. Epub 2017 Oct 9. Review.</citation>
    <PMID>29024799</PMID>
  </reference>
  <reference>
    <citation>Calì G, Timor-Tritsch IE, Palacios-Jaraquemada J, Monteaugudo A, Buca D, Forlani F, Familiari A, Scambia G, Acharya G, D'Antonio F. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018 Feb;51(2):169-175. doi: 10.1002/uog.17568. Review.</citation>
    <PMID>28661021</PMID>
  </reference>
  <results_reference>
    <citation>Antila-Långsjö RM, Mäenpää JU, Huhtala HS, Tomás EI, Staff SM. Cesarean scar defect: a prospective study on risk factors. Am J Obstet Gynecol. 2018 Nov;219(5):458.e1-458.e8. doi: 10.1016/j.ajog.2018.09.004. Epub 2018 Sep 18.</citation>
    <PMID>30240650</PMID>
  </results_reference>
  <results_reference>
    <citation>Ades A, Parghi S. Laparoscopic Resection of Cesarean Scar Ectopic Pregnancy. J Minim Invasive Gynecol. 2017 May - Jun;24(4):533-535. doi: 10.1016/j.jmig.2016.11.006. Epub 2016 Nov 17.</citation>
    <PMID>27867050</PMID>
  </results_reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 24, 2019</study_first_submitted>
  <study_first_submitted_qc>May 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 29, 2019</study_first_posted>
  <last_update_submitted>June 25, 2019</last_update_submitted>
  <last_update_submitted_qc>June 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Uludag University</investigator_affiliation>
    <investigator_full_name>Adnan Orhan</investigator_full_name>
    <investigator_title>Medical Doctor, Researcher, Obstetrician and Gynecologist</investigator_title>
  </responsible_party>
  <keyword>Cesarean scar pregnancy</keyword>
  <keyword>Isthmocele</keyword>
  <keyword>Uterine niche</keyword>
  <keyword>Cesarean scar defect</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Deidentified individual participant data for all primary and secondary outcomes will be made available.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Data will be available within nine months after the study completion.</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by an external independent review panel. Requesters will be required to sign a data access agreement form.</ipd_access_criteria>
    <ipd_url>http://www.uludag.edu.tr</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

